	US 12,336,972 B2
	Synergistic nutritional compositions for treating neurocognitive disorders
Rajaram Samant, Thane West (IN); and Rajendra Prasad Tongra, Jaipur (IN)
Assigned to CELAGENEX RESEARCH (INDIA) PVT. LTD., Thane (IN)
Filed by CELAGENEX RESEARCH (INDIA) PVT. LTD., Maharashtra (IN)
Filed on Jan. 7, 2022, as Appl. No. 17/571,105.
Claims priority of application No. 202021046067 (IN), filed on Jan. 22, 2021.
Prior Publication US 2022/0233484 A1, Jul. 28, 2022
Int. Cl. A61K 31/198 (2006.01); A61K 9/00 (2006.01); A61K 31/185 (2006.01); A61P 25/28 (2006.01)

CPC A61K 31/198 (2013.01) [A61K 9/0053 (2013.01); A61K 31/185 (2013.01); A61P 25/28 (2018.01)]

4 Claims

1. A nutritional composition for treating neurocognitive disorder, the nutritional composition comprising:

an exogenous blend; and

pharmaceutically acceptable excipients,

wherein the exogenous blend consists of magnesium L-threonate in a range of 50 to 250 mg and homotaurine in a range of 25 to 50 mg.